HealthMarkets facing multistate probe

Sep 06, 2007

Insurance regulators in 36 states are investigating the sales practices of two insurance companies owned by HealthMarkets, a report says.

Massachusetts Attorney General Martha Coakley last month charged Mega Life and Mid-West National of deception and unfair practices for allegedly not telling customers that standard health insurance policies didn't cover things like office visits, prescription drugs or chemotherapy, USA Today said Wednesday.

The company has been fined by seven states in the past five years.

HealthMarkets Chief Executive Officer William Gedwed, who took over in 2003, said the company denies and disagrees with the allegation in the Massachusetts attorney general's lawsuit.

"From at least 2003 on, we've put a tremendous amount of effort into ensuring we do things the way regulators want," he said.

Gedwed said HealthMarkets began making follow-up phone calls to new customers starting in 2005 to make sure they understood their policies, the newspaper said.

Copyright 2007 by United Press International

Explore further: Face transplants change lives, identity

add to favorites email to friend print save as pdf

Related Stories

A new multi-bit 'spin' for MRAM storage

2 hours ago

Interest in magnetic random access memory (MRAM) is escalating, thanks to demand for fast, low-cost, nonvolatile, low-consumption, secure memory devices. MRAM, which relies on manipulating the magnetization ...

Bats use polarized light to navigate

2 hours ago

Scientists have discovered that greater mouse-eared bats use polarisation patterns in the sky to navigate – the first mammal that's known to do this.

Recommended for you

Face transplants change lives, identity

5 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments : 0